There's an unmet need for effective treatments in PTSD, as current options include psychotherapy and the SSRIs sertraline and paroxetine (Paxil). These options carry various adverse effects, and the ...

Mixed states in bipolar combine symptoms of mania and depression. Learn how to recognize them and why they can be so hard to ...

A major new study from Johns Hopkins Medicine has revealed a strong link between chronic pain and mental health. After ...

PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo in Major Depressive Disorder (MDD) ...

Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress BUOY-1 builds on ...

PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress ...

Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder Investor & Media Contact: Gabriel ...

The Company previously received Breakthrough Therapy Designation from the U.S. Food and Drug Administration ("FDA") for CYB003 for the adjunctive treatment of Major Depressive Disorder ("MDD").

Disturbing new studies indicate cannabis use in adolescents and young adults significantly increases risk for suicidal behaviors.